Alisdair Leeson

Alisdair Leeson discloses dealings in Asia Green Biotechnology Corp. to SEDI. We count 3 filings, every one of them for a trade on 21 January 2021.

The filings describe grants, exercises and other transfers rather than trades on the open market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 1 February 2021, reports a transaction in Asia Green Biotechnology Corp. The median gap between a trade and its publication by SEDI is 11 days. The shorter that gap, the sooner other investors can see what insiders have done. This summary is built from SEDI disclosures alone and does not predict where the share price will go.